We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

54 hedge funds and large institutions have $32.7M invested in Neos Therapeutics, Inc in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

8% more capital invested

Capital invested by funds: $30.4M → $32.7M (+$2.33M)

6% more funds holding

Funds holding: 51 → 54 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

33% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 15

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $23K

Holders
54
Holders Change
+3
Holders Change %
+5.88%
% of All Funds
1.06%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
10
Reduced
15
Closed
5
Calls
–
Puts
$23K
Net Calls
-$23K
Net Calls Change
-$16K

Top Buyers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
+$871K
2
SCM
Stonepine Capital Management
Oregon
+$535K
3
Renaissance Technologies
Renaissance Technologies
New York
+$388K
4
Boston Partners
Boston Partners
Massachusetts
+$344K
5
Goldman Sachs
Goldman Sachs
New York
+$204K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$566K
2
PP
Paloma Partners
Connecticut
-$159K
3
OAM
Oxford Asset Management
United Kingdom
-$97.3K
4
Citigroup
Citigroup
New York
-$90.7K
5
WG
Winton Group
United Kingdom
-$58.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BWM
26
BCS Wealth Management
Tennessee
$45K +$44.3K +29,520 New
Millennium Management
27
Millennium Management
New York
$44K -$17.6K -11,761 -29%
VF
28
Virtu Financial
New York
$42K +$41.7K +27,813 New
ACM
29
Allred Capital Management
Texas
$37.7K – – –
State Street
30
State Street
Massachusetts
$37K -$22.4K -14,961 -38%
SCM
31
Southport Capital Management
Tennessee
$36K – – –
Charles Schwab
32
Charles Schwab
California
$32K – – –
TRCT
33
Tower Research Capital (TRC)
New York
$27K +$6.45K +4,302 +32%
William Blair & Company
34
William Blair & Company
Illinois
$25K +$24.6K +16,400 New
CIBC Private Wealth Group
35
CIBC Private Wealth Group
Georgia
$23K – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$21K – – –
AG
37
Advisor Group
Arizona
$20K – – –
Commonwealth Equity Services
38
Commonwealth Equity Services
Massachusetts
$20K +$3K +2,000 +17%
Deutsche Bank
39
Deutsche Bank
Germany
$17K -$20.6K -13,743 -54%
RJA
40
Raymond James & Associates
Florida
$16K – – –
SCA
41
Stonebridge Capital Advisors
Minnesota
$15K – – –
Bank of America
42
Bank of America
North Carolina
$15K +$13.3K +8,891 +802%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$12K – – –
MAM
44
Meeder Asset Management
Ohio
$11K – – –
UBS Group
45
UBS Group
Switzerland
$8K +$4.57K +3,045 +152%
Group One Trading
46
Group One Trading
Illinois
$7K – – –
Citigroup
47
Citigroup
New York
$2K -$90.7K -60,438 -98%
LTFS
48
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Rockefeller Capital Management
49
Rockefeller Capital Management
New York
$1K – – –
TFGT
50
TS Financial Group (TSFG)
Illinois
$1K – – –
1
2
3

NEOS Hedge Fund Activity: Q4 2019 in Review

54 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q4 2019, worth a combined $32.7M — up 7.7% from $30.4M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NEOS positions and 5 closed out — a net gain of 3 holders — while 10 added to existing stakes and 15 trimmed.

The largest buyer was Russell Investments Group, opening a new position worth an estimated $871K. The largest seller was Sphera Funds Management, cutting an estimated $566K.

  • 54 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q4 2019, up from 51 in Q3 2019.
  • Funds reported $32.7M of Neos Therapeutics, Inc stock for Q4 2019, up 7.7% quarter-over-quarter.
  • 8 funds opened new Neos Therapeutics, Inc positions in Q4 2019 and 5 closed out, a net change of +3 holders.
  • The largest Neos Therapeutics, Inc buyer in Q4 2019 was Russell Investments Group, an estimated $871K added.
  • The largest Neos Therapeutics, Inc seller in Q4 2019 was Sphera Funds Management, an estimated $566K sold.

Based on aggregated 13F filings for Q4 2019.